EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Molecular Responses of Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration: Integrative Insights From Multi-Omics and Clinical Imaging

Xuenan Zhuang, Miaoling Li, Lan Mi, Xiongze Zhang, Jiaxin Pu, Guiqin He, Liang Zhang, Honghua Yu, Liwei Yao, Hui Chen, Yuying Ji, Chengguo Zuo and 6 more

Investigative Ophthalmology & Visual Science · 2024-08-16 · 65 (10) · 24

DOI: 10.1167/iovs.65.10.24 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2024-08-16. Written by Xuenan Zhuang and 17 co-authors. Institution: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Major MEDLINE topics: Tomography, Optical Coherence, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Wet Macular Degeneration. Cited 10 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

The purpose of this study was to investigate the molecular mechanisms underlying anti-vascular endothelial growth factor (anti-VEGF) efficacy and response variability in neovascular age-related macular degeneration (nAMD) using longitudinal proteomic and metabolomic analysis alongside three-dimensional lesion measurements.

Methods

In this prospective study, 54 treatment-naive patients with nAMD underwent "3+ pro re nata" (3+PRN) anti-VEGF regimens followed for at least 12 weeks. Aqueous humors were collected pre- and post-treatment for proteomic and metabolomic analysis. Three-dimensional optical coherence tomography (OCT) and OCT angiography assessed different types of nAMD lesion volumes and areas.

Results

There were 1350 proteins and 1268 metabolites that were identified in aqueous humors, with 301 proteins and 353 metabolites significantly altered during anti-VEGF treatment, enriched in pathways of angiogenesis, energy metabolism, signal transduction, and neurofunctional regulation. Sixty-seven changes of (Δ) molecules significantly correlated with at least one type of ΔnAMD lesion. Notably, proteins FGA, TALDO1, and ASPH significantly decreased during treatment, with their reductions correlating with greater lesion regression in at least two lesion types. Conversely, despite that YIPF3 also showed significant downregulation, its decrease was associated with poorer regression in total nAMD lesion and subretinal hyper-reflective material.

Conclusions

This study identifies FGA, TALDO1, and ASPH as potential key molecules in the efficacy of anti-VEGF therapy, whereas YIPF3 may be a key factor in poor response. The integration of longitudinal three-dimensional lesion analysis with multi-omics provides valuable insights into the mechanisms and response variability of anti-VEGF treatment in nAMD.

Subjects

MeSH terms (MEDLINE)

Tomography, Optical CoherenceAngiogenesis InhibitorsVascular Endothelial Growth Factor AWet Macular DegenerationProteomicsFluorescein AngiographyIntravitreal InjectionsRanibizumabHumansProspective StudiesMaleFemaleAgedAged, 80 and overAqueous HumorBevacizumabMetabolomicsVisual AcuityImaging, Three-DimensionalMultiomics

Substances

Angiogenesis InhibitorsVascular Endothelial Growth Factor ARanibizumabBevacizumabVEGFA protein, human

Authors and institutions

  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocul…
  • Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Cite

APA

Zhuang, X., Li, M., Mi, L., Zhang, X., Pu, J., He, G., Zhang, L., Yu, H., Yao, L., Chen, H., Ji, Y., Zuo, C., Su, Y., Gan, Y., Hao, X., Zhang, Y., Chen, X., & Wen, F. (2024). Molecular Responses of Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration: Integrative Insights From Multi-Omics and Clinical Imaging. Investigative Ophthalmology & Visual Science, 65(10), 24. https://doi.org/10.1167/iovs.65.10.24

Vancouver

Zhuang X, Li M, Mi L, Zhang X, Pu J, He G, et al. Molecular Responses of Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration: Integrative Insights From Multi-Omics and Clinical Imaging. Investigative Ophthalmology & Visual Science. 2024;65(10):24. doi:10.1167/iovs.65.10.24

BibTeX
@article{Zhuang2024,
  author = {Zhuang, Xuenan and Li, Miaoling and Mi, Lan and Zhang, Xiongze and Pu, Jiaxin and He, Guiqin and Zhang, Liang and Yu, Honghua and Yao, Liwei and Chen, Hui and Ji, Yuying and Zuo, Chengguo and Su, Yongyue and Gan, Yuhong and Hao, Xinlei and Zhang, Yining and Chen, Xuelin and Wen, Feng},
  title = {Molecular Responses of Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration: Integrative Insights From Multi-Omics and Clinical Imaging},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  volume = {65},
  number = {10},
  pages = {24},
  doi = {10.1167/iovs.65.10.24}
}
Start for free →